Shionogi & Co., Ltd. (SGIOF)
18.91
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Shionogi EPS Diluted (Quarterly) : 0.7203 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7203 |
| March 31, 2026 | 0.3514 |
| December 31, 2025 | 0.5695 |
| September 30, 2025 | 0.3521 |
| June 30, 2025 | 0.3199 |
| March 31, 2025 | 0.2824 |
| December 31, 2024 | 0.3908 |
| September 30, 2024 | 0.4134 |
| June 30, 2024 | 0.2311 |
| March 31, 2024 | 0.2743 |
| December 31, 2023 | 0.286 |
| September 30, 2023 | 0.3782 |
| June 30, 2023 | 0.3504 |
| March 31, 2023 | 0.233 |
| December 31, 2022 | 0.8014 |
| September 30, 2022 | 0.1806 |
| June 30, 2022 | 0.2956 |
| March 31, 2022 | 0.4104 |
| December 31, 2021 | 0.1737 |
| September 30, 2021 | 0.2098 |
| June 30, 2021 | 0.3257 |
| March 31, 2021 | 0.2687 |
| December 31, 2020 | 0.3793 |
| September 30, 2020 | 0.2818 |
| June 30, 2020 | 0.2498 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.281 |
| December 31, 2019 | 0.3964 |
| September 30, 2019 | 0.2714 |
| June 30, 2019 | 0.2638 |
| March 31, 2019 | 0.3719 |
| December 31, 2018 | 0.3433 |
| September 30, 2018 | 0.2443 |
| June 30, 2018 | 0.3052 |
| March 31, 2018 | 0.2805 |
| December 31, 2017 | 0.2683 |
| September 30, 2017 | 0.3184 |
| June 30, 2017 | 0.1483 |
| March 31, 2017 | 0.1487 |
| December 31, 2016 | 0.3374 |
| September 30, 2016 | 0.1838 |
| June 30, 2016 | 0.1171 |
| March 31, 2016 | 0.219 |
| December 31, 2015 | 0.1684 |
| September 30, 2015 | 0.0968 |
| June 30, 2015 | 0.0802 |
| March 31, 2015 | 0.1499 |
| December 31, 2014 | 0.1441 |
| September 30, 2014 | -0.0059 |
| June 30, 2014 | 0.0977 |
| March 31, 2014 | 0.0445 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
| Santen Pharmaceutical Co., Ltd. | 0.1399 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 613.21M |
| Revenue (Quarterly) | 1.025B |
| Total Expenses (Quarterly) | 411.75M |
| Enterprise Value | 18.46B |
| Gross Profit Margin (Quarterly) | 71.45% |
| Profit Margin (Quarterly) | 59.84% |
| Earnings Yield | 10.54% |
| Operating Earnings Yield | 6.65% |
| Normalized Earnings Yield | 10.54 |